Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin

FEBS Letters

Volumn 437, Issue 1-2, 1998, Pages 97-100

  Larminat, Florence ^a   Cambois, Gilles ^a   Zdzienicka, Małgorzata Z ^b   Defais, Martine ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Cisplatin; DNA repair; Interstrand cross link; Mitomycin C

Indexed keywords

CISPLATIN; MITOMYCIN C;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; DRUG CYTOTOXICITY; EXCISION REPAIR; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CISPLATIN; COLONY-FORMING UNITS ASSAY; CRICETINAE; CRICETULUS; CROSS-LINKING REAGENTS; DNA REPAIR; MITOMYCIN; MUTATION;

EID: 0032538533     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01209-5     Document Type: Article

References (28)

1. Kohn K.W. Cancer Res. 56:1996;5533-5546.
2. Fichtinger-Schepman A.M.J., van der Veer J.L., den Hartog J.H.J., Loman P.H.M., Reedijk J. Biochemistry. 24:1985;707-713.
3. Tomasz M., Lipman R. Biochemistry. 20:1981;5056-5061.
4. Szymkowski D.E., Yarema K., Essigmann J.-M., Lippard S.J., Wood R.D. Proc. Natl. Acad. Sci. USA. 89:1992;10772-10776.
5. Larminat F., Bohr V.A. Nucleic Acids Res. 22:1994;3005-3010.
6. Plooy A.C.M., van Dijk M., Berends F., Lohman P.H.M. Cancer Res. 45:1985;4178-4184.
7. Demarcq C., Bunch R.T., Creswell D., Eastman A. Cell Growth Differ. 5:1994;983-993.
8. Zdzienicka M.Z., Simons J.W.I.M. Mutat. Res. 194:1987;239-249.
9. Jones N.J. Mutagenesis. 9:1994;477-482.
10. Telleman P., Overkamp W.I.J., van Wessel N., Studzian K., Wetselaar L., Natarajan A.T., Zdzienicka M.Z. Cancer Res. 55:1995;3412-3416.
11. Zdzienicka M.Z., Arwert F., Neuteboom I., Rooimans M., Simons J.W.I.M. Somat. Cell Mol. Genet. 6:1990;575-581.
12. Overkamp W.J.I., Rooimans M.A., Neuteboom I., Telleman P., Arwert F., Zdzienicka M.Z. Somat. Cell Mol. Genet. 19:1993;431-437.
13. Arwert F., Rooimans M., Westerfeld A., Simons J.W.I.M., Zdzienicka M.Z. Cytogenet. Cell Genet. 56:1991;23-26.
14. Vos J.-M., Hanawalt P.C. Cell. 50:1987;789-799.
15. Jones J., Zhen W., Reed E., Parker R.J., Sancar A., Bohr V.A. J. Biol. Chem. 266:1991;7101-7107.
16. Hoy C.A., Thompson L.H., Mooney C.L., Salazar E.P. Cancer Res. 45:1985;1737-1743.
17. Miller S.A., Dykes D.D., Polesky H.F. Nucleic Acids Res. 16:1988;1215.
18. Gonzales I.L., Gorski J.L., Campen T.J., Dorney D.J., Erickson J.M., Sylvester J.E., Schimkel R.D. Proc. Natl. Acad. Sci. USA. 82:1985;7666-7670.
19. Verweij, J. and Pinedo, H.M. (1991) in: Cancer Chemotherapy and Biological Modification (Pinedo, H.M., Longo, D.L. and Chabner, B.A., Eds.), Vol. 12, pp. 59-65, Elsevier Science, Amsterdam.
20. Dulhanty A.M., Li M., Whitmore G.F. Cancer Res. 49:1989;117-122.
21. Dusre L., Rajagopalan S., Eliot H.M., Covey J.M., Sinha B.K. Cancer Res. 50:1990;648-652.
22. Dorr R.T., Bowden G.T., Alberts D.S., Liddil J.D. Cancer Res. 45:1985;3510-3516.
23. Sognier M.A., Hittelman W.N. Cancer Res. 46:1986;4032-4040.
24. Tomasz M. Chem. Biol. 2:1995;575-579.
25. Matsumoto A., Vos J.-M.H., Hanawalt P.C. Mutat. Res. 217:1989;185-192.
26. Rey J.-P., Scott R., Muller H. Mutat. Res. 289:1993;171-180.
27. Larminat F., Zhen W., Bohr V.A. J. Biol. Chem. 268:1993;2649-2654.
28. Stevnsner T., May A., Petersen L.N., Larminat F., Pirsel M., Bohr V.A. Carcinogenesis. 14:1993;1591-1596.